Drug Approval Package
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Drug Approval Package

  • Print
  • Share
  • E-mail

Drug Name: Zelapar (selegiline hydrochloride) Orally Disintegrating Tablets, 1.25 mg
Company: Valeant Pharmaceuticals International
NDA: 021479
Approval Date: 6/14/2006


Date created: January 15, 2009

Back to Top    Drugs@FDA


Note: Documents in PDF format require the Adobe Acrobat Reader®.